brimonidine tartrate has been researched along with methylprednisolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadi, MA; Anderlini, P; Esmaeli, B; Kim, RY; Naderi, AA; Rivera, P | 1 |
Donald, CB; Mendez, AP; Pierce, BD | 1 |
Hong, JY; Kim, BJ; Kim, MN; Lee, HW; Park, KY | 1 |
3 other study(ies) available for brimonidine tartrate and methylprednisolone
Article | Year |
---|---|
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
Topics: Acetazolamide; Bone Marrow Transplantation; Brimonidine Tartrate; Choroid Diseases; Drug Therapy, Combination; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pain; Quinoxalines; Scleritis; Transplantation, Homologous | 2002 |
Eye problems in a woman with Churg-Strauss syndrome.
Topics: Administration, Ophthalmic; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Churg-Strauss Syndrome; Edema; Exophthalmos; Eye Diseases; Eyelids; Female; Glucocorticoids; Humans; Latanoprost; Methylprednisolone; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic | 2017 |
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatitis; Gels; Humans; Hyperpigmentation; Lasers, Solid-State; Lentigo; Male; Methylprednisolone; Middle Aged | 2018 |